GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Balance Sheet Cash And Cash Equivalents

Alto Neuroscience (Alto Neuroscience) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Alto Neuroscience (Alto Neuroscience) Business Description

Industry
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.